4 ideas to kick-start U.S. drug research — and beat China in biotech

Taking stock of the drug industry, from the lab to the medicine chest

June 3, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | Opinion: 4 ideas to kick-start U.S. drug research — and beat China in biotech There's no reason the U.S. can't pick up the pace to match the global clinical research front-runners without compromising safety. By Brian Finrow and Sandeep Patel Pluvicto pushes earlier in prostate cancer play Today's biotech news covers Pluvicto's prostate cancer play, J&J's big bets on bladder, lung, and talent, and more. By Meghana Keshavan Opinion: RFK Jr.'s stance on Covid vaccines for pregnant women is profoundly unethical HHS Secretary Robert Kennedy is setting back decades of work on maternal health with an unethical move on Covid vaccine recommendations, expert says. By Ruth R. Faden

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser